다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

GLPG

Galapagos NV (GLPG)

Galapagos NV

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:GLPG

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/31	05:44	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2024/05/31	05:01	GlobeNewswire Inc.	Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications	NASDAQ:GLPG	Galapagos NV
2024/05/17	05:28	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2024/05/17	05:01	GlobeNewswire Inc.	Galapagos creates new subscription right plans	NASDAQ:GLPG	Galapagos NV
2024/05/16	21:11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2024/05/16	05:01	GlobeNewswire Inc.	Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.	NASDAQ:GLPG	Galapagos NV
2024/05/03	05:01	GlobeNewswire Inc.	Galapagos reports first quarter 2024 financial results	NASDAQ:GLPG	Galapagos NV
2024/05/01	05:01	GlobeNewswire Inc.	Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024	NASDAQ:GLPG	Galapagos NV
2024/04/05	05:01	GlobeNewswire Inc.	Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024	NASDAQ:GLPG	Galapagos NV
2024/03/29	05:01	GlobeNewswire Inc.	Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings	NASDAQ:GLPG	Galapagos NV
2024/03/27	05:01	GlobeNewswire Inc.	Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board	NASDAQ:GLPG	Galapagos NV
2024/02/23	20:41	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2024/02/23	06:01	GlobeNewswire Inc.	Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline	NASDAQ:GLPG	Galapagos NV
2024/02/23	06:01	GlobeNewswire Inc.	Galapagos announces full year 2023 results and outlook for 2024	NASDAQ:GLPG	Galapagos NV
2024/02/16	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2024/02/16	06:01	GlobeNewswire Inc.	Galapagos presents at EBMT-EHA annual meeting 2024	NASDAQ:GLPG	Galapagos NV
2024/02/15	07:41	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GLPG	Galapagos NV
2024/02/01	06:01	GlobeNewswire Inc.	Galapagos completes transaction to transfer Jyseleca® business to Alfasigma	NASDAQ:GLPG	Galapagos NV
2024/01/05	06:44	Dow Jones News	Galapagos, Thermo Fisher to Collaborate on Expanding Manufacturing of Cancer Drug	NASDAQ:GLPG	Galapagos NV
2024/01/05	06:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2024/01/05	06:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2024/01/05	06:01	GlobeNewswire Inc.	Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.	NASDAQ:GLPG	Galapagos NV
2024/01/04	06:01	GlobeNewswire Inc.	Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology	NASDAQ:GLPG	Galapagos NV
2024/01/04	06:01	PR Newswire (US)	BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets	NASDAQ:GLPG	Galapagos NV
2024/01/02	15:00	GlobeNewswire Inc.	Galapagos signs agreement to transfer Jyseleca® business to Alfasigma	NASDAQ:GLPG	Galapagos NV
2023/12/22	06:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2023/12/20	06:01	GlobeNewswire Inc.	Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301	NASDAQ:GLPG	Galapagos NV
2023/12/10	02:00	GlobeNewswire Inc.	Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101	NASDAQ:GLPG	Galapagos NV
2023/12/08	06:01	GlobeNewswire Inc.	Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023	NASDAQ:GLPG	Galapagos NV
2023/11/06	21:45	PR Newswire (US)	Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-Care	NASDAQ:GLPG	Galapagos NV

검색 관련기사 보기:NASDAQ:GLPG

1 2 3 4 5 6 7 8 9 10 다음 >>

BNP Paribas (QX)

Bank of America

Deutsche Telekom (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관